Physician

John H Ellis, M.D.

According to 2025 Medicare claims, John Ellis, M.D. (NPI: 1316088669) practices cardiology in the Scranton--Wilkes-Barre, PA market, with the plurality of this provider's patient population coming from Luzerne, PA. This provider's primary affiliated billing organization is NORTHEASTERN PENNSYLVANIA CARDIOLOGY ASSOCIATES LLP (NPI: 1043351281; TIN: 232969438) and primary practice location at 18705-1090.

Ellis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,310 traditional Medicare patients, billed 6,893 HCPCS/CPT codes, and received $442,118 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 9,605 prescription claims across 1,230 beneficiaries totaling $989,503 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 58 claims. Open Payments data shows 111 records totaling $1,730. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $326,003 to $989,503. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $34,582 and ending at $15,884.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,329	11,351	$540,907
2016	1,938	10,329	$520,216
2017	1,713	10,275	$559,858
2018	1,442	11,340	$628,468
2019	1,476	11,179	$648,566
2020	1,418	8,066	$508,950
2021	1,386	6,863	$457,037
2022	1,291	6,329	$439,882
2023	1,278	6,983	$442,385
2024	1,310	6,893	$442,118

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	744	10,783	$326,003
2016	802	11,312	$342,833
2017	846	11,508	$427,680
2018	944	13,374	$622,437
2019	1,044	13,342	$780,095
2020	1,081	12,340	$820,207
2021	1,024	10,793	$910,201
2022	1,052	9,814	$833,125
2023	1,138	9,320	$907,174
2024	1,230	9,605	$989,503

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	16	$34,377
2017	N/R	13	$836
2018	N/R	58	$50,245
2019	N/R	58	$39,643
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	178	178	$315
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	170	190	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	873	2,079	$85
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	173	175	$85
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	876	2,018	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	493	21,700	$409,148
Xarelto	Rivaroxaban	181	8,610	$156,731
Entresto	Sacubitril/Valsartan	143	5,950	$130,428
Repatha Sureclick	Evolocumab	74	2,670	$50,324
Jardiance	Empagliflozin	57	2,056	$39,525

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	111	$1,730	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John H. Ellis, M.D.?

Tedicare shows public-source Medicare data for John H. Ellis, M.D. (NPI 1316088669), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John H. Ellis, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John H. Ellis, M.D.?

John H. Ellis, M.D. is linked to NORTHEASTERN PENNSYLVANIA CARDIOLOGY ASSOCIATES LLP (billing NPI 1043351281) in the available physician profile data.

Does John H. Ellis, M.D. have Open Payments data?

John H. Ellis, M.D. has 111 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.